Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China
· Delayed Price · Currency is CNY 93.57
+1.50 (1.63%)
Apr 29, 2026, 3:00 PM CST
SHA:688578 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 41,432 | 46,868 | 26,955 | 18,747 | 8,856 | 13,590 | Upgrade
|
| Market Cap Growth | 7.94% | 73.87% | 43.78% | 111.69% | -34.83% | 6.04% | Upgrade
|
| Enterprise Value | 38,277 | 43,593 | 23,927 | 16,494 | 6,916 | 11,015 | Upgrade
|
| Last Close Price | 92.07 | 104.15 | 59.45 | 40.84 | 19.29 | 29.61 | Upgrade
|
| PE Ratio | 17.17 | 21.41 | 18.85 | 29.10 | 67.85 | 743.66 | Upgrade
|
| Forward PE | 15.66 | 22.45 | 17.64 | 28.70 | 74.26 | 109.82 | Upgrade
|
| PS Ratio | 7.30 | 9.04 | 7.58 | 9.29 | 11.20 | 25.64 | Upgrade
|
| PB Ratio | 5.35 | 6.62 | 5.10 | 4.71 | 2.78 | 4.57 | Upgrade
|
| P/TBV Ratio | 5.47 | 6.79 | 5.17 | 4.79 | 2.84 | 4.68 | Upgrade
|
| P/FCF Ratio | 17.65 | 21.94 | 20.80 | 30.90 | - | - | Upgrade
|
| P/OCF Ratio | 16.68 | 20.18 | 17.21 | 27.79 | 96.65 | 463.96 | Upgrade
|
| EV/Sales Ratio | 6.75 | 8.40 | 6.73 | 8.17 | 8.74 | 20.78 | Upgrade
|
| EV/EBITDA Ratio | 14.64 | 18.66 | 15.83 | 28.18 | 117.62 | - | Upgrade
|
| EV/EBIT Ratio | 14.89 | 18.98 | 16.22 | 30.08 | 179.00 | - | Upgrade
|
| EV/FCF Ratio | 16.31 | 20.40 | 18.47 | 27.18 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0 | 0 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | - | Upgrade
|
| Debt / FCF Ratio | 0.00 | 0.00 | 0.00 | 0.00 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.41 | -0.50 | -0.69 | -0.63 | -0.64 | -0.76 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.21 | -1.52 | -2.40 | -4.29 | -34.61 | 40.26 | Upgrade
|
| Net Debt / FCF Ratio | -1.34 | -1.66 | -2.80 | -4.14 | 38.99 | 13.84 | Upgrade
|
| Asset Turnover | 0.77 | 0.75 | 0.69 | 0.52 | 0.24 | 0.17 | Upgrade
|
| Inventory Turnover | 4.42 | 3.22 | 3.07 | 1.64 | 1.78 | 1.90 | Upgrade
|
| Quick Ratio | 4.41 | 4.92 | 6.73 | 7.18 | 8.62 | 14.59 | Upgrade
|
| Current Ratio | 5.25 | 5.18 | 6.96 | 7.46 | 8.98 | 15.21 | Upgrade
|
| Return on Equity (ROE) | 36.09% | 35.41% | 30.86% | 17.97% | 4.24% | 0.63% | Upgrade
|
| Return on Assets (ROA) | 21.68% | 20.77% | 17.91% | 8.77% | 0.73% | -1.43% | Upgrade
|
| Return on Invested Capital (ROIC) | 54.33% | 76.00% | 83.25% | 41.02% | 4.13% | -13.81% | Upgrade
|
| Return on Capital Employed (ROCE) | 33.10% | 32.40% | 27.70% | 13.80% | 1.20% | -2.30% | Upgrade
|
| Earnings Yield | 5.83% | 4.67% | 5.30% | 3.44% | 1.47% | 0.13% | Upgrade
|
| FCF Yield | 5.67% | 4.56% | 4.81% | 3.24% | -0.59% | -1.20% | Upgrade
|
| Dividend Yield | 1.30% | 0.96% | 1.09% | 0.98% | - | - | Upgrade
|
| Payout Ratio | 14.91% | 16.45% | 20.46% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.12% | -0.18% | 0.18% | -0.09% | 1.49% | -23.59% | Upgrade
|
| Total Shareholder Return | 1.20% | 0.78% | 1.28% | 0.89% | 1.49% | -23.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.